Rayence Co., Ltd. (KOSDAQ:228850)
South Korea · Delayed Price · Currency is KRW
6,350.00
+110.00 (1.76%)
At close: Mar 20, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Manufacture & Sale of X-Ray Detectors & Imaging Medical Devices for Animals | | | 142.99B | 147.16B | 134.57B | 101.52B | 126.17B | | | |
Manufacture & Sale of X-Ray Detectors & Imaging Medical Devices for Animals Growth | | | -2.84% | 9.36% | 32.55% | -19.54% | 8.41% | | | |
| | | 142.99B | 147.16B | 134.57B | 101.52B | 126.17B | | | |
| | | -2.84% | 9.36% | 32.55% | -19.54% | 8.41% | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 23.72B | 32.69B | 31.07B | 18.92B | - | | | |
North and South America Growth | | | -27.44% | 5.21% | 64.28% | - | - | | | |
| | | 134.20B | 137.29B | 125.76B | 99.33B | 64.08B | | | |
| | | -2.25% | 9.17% | 26.61% | 55.00% | 15.82% | | | |
| | | -15.83B | -24.50B | -22.46B | -16.72B | - | | | |
| | | 894.73M | 1.68B | 194.82M | - | - | | | |
| | | -46.68% | 761.30% | - | - | - | | | |
| | | - | - | - | - | 62.09B | | | |
| | | - | - | - | - | 1.69% | | | |
| | | 142.99B | 147.16B | 134.57B | 101.52B | 126.17B | | | |
| | | -2.84% | 9.36% | 32.55% | -19.54% | 8.41% | | | |
Source: S&P Global Market Intelligence.